Antibody Fc receptor binding and T cell responses to homologous and heterologous immunization with inactivated or mRNA vaccines against SARS-CoV-2

A(H2N2) and A(H3N2) influenza pandemics elicited durable cross-reactive and protective antibodies against avian N2 neuraminidases

Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin

Influenza antibody breadth and effector functions are immune correlates from acquisition of pandemic infection of children

Amino acids in the polymerase complex of shorebird-isolated H1N1 influenza virus impact replication and host-virus interactions in mammalian models

1,000 Participants: A New Milestone Reached For HHGP-Hong Kong

Stability of SARS-CoV-2 on Commercial Aircraft Interior Surfaces

[Press Release] SARS-CoV-2: How The History Of Human Populations Influences Their Immune Response

SARS-CoV-2: Comparative study on third-dose booster with either one dose of CoronaVac or BNT162b2

Broad-spectrum pan-genus and pan-family virus vaccines

SARS-CoV2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia

Resurgence of Omicron BA.2 in SARS-CoV-2 infection-naive Hong Kong

Replication of Novel Zoonotic-Like Influenza A(H3N8) Virus in Ex Vivo Human Bronchus and Lung

Within-host genetic diversity of SARS-CoV-2 lineages in unvaccinated and vaccinated individuals

[HHGP-HK] Join the study!

C2i & HKUMed Investigate Vaccine Effectiveness Against Omicron Infection

Vector Control and Insecticide Resistance Presentation

Development of multiplex RT-ddPCR assays for detection of SARS-CoV-2 and other respiratory viruses

Meet Our Team: Mark Zanin

Inside C2i | What is Growth Kinetics?